Medicines and Healthcare products Regulatory Agency

Featured

Sparsentan approved to treat adult patients with primary immunoglobulin A nephropathy (IgAN)

News story

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine sparsentan (Filspari) to treat primary immunoglobulin A nephropathy (IgAN).

The MHRA seeks views on pre-market regulations for medical devices to improve patient access and strengthen patient safety

News story

Responses will help shape reforms that will boost UK patients’ access to safe and innovative medical products

The importance of giving patients a voice in the approval of new sickle cell treatment

Case study

This case study is an example of how the MHRA is benefiting from patients providing their lived experience for the pre-authorisation stage of the benefit-risk review.

Red blood cells

MedSafetyWeek 2024: Preventing side effects 

News story

The ninth annual #MedSafetyWeek takes place this week, with regulators from 94 countries and 107 organisations taking part across the globe. 

Sugemalimab approved to treat adult patients with non-small cell lung cancer     

Press release

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 30 October, approved the medicine sugemalimab (Eqjubi) to treat adult patients with a type of lung cancer called ‘non-small cell lung cancer’. 

MHRA reminds healthcare professionals to advise patients of the side effects of GLP-1 agonists and to report misuse

Press release

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding healthcare professionals to ensure patients are aware of the known side effects of glucagon-like peptide-1 (GLP-1) receptor agonists.

Latest from the Medicines and Healthcare products Regulatory Agency

See all latest documents

Subscriptions

What we do

The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.

MHRA is an executive agency, sponsored by the Department of Health and Social Care.

Read more about what we do

Follow us

Services

See all services

Guidance and regulation

See all guidance and regulation

News and communications

See all news and communications

Research and statistics

See all research and statistics

Policy papers and consultations

See all policy papers and consultations

Transparency and freedom of information releases

See all transparency and freedom of information releases

Our management

Dame June Raine DBE
Chief Executive
Amanda Calvert
Interim co-chair
Professor Graham Cooke
Interim co-chair
Michael Whitehouse OBE
Interim co-chair
Liz Booth
Chief People Officer
Rose Braithwaite
Chief Finance Officer
Dr Alison Cave
Chief Safety Officer
Claire Harrison
Chief Digital and Technology Officer
Dr Laura Squire OBE
Chief Healthcare Quality & Access Officer
Rachel Bosworth
Director of Communications and Engagement
Mick Foy
Director of Delivery
Carly McGurry
Director of Governance
Nicola Rose
Interim Executive Director, Science and Research
James Pound
Interim Executive Director, Innovation and Compliance
Julian Beach
Interim Executive Director Healthcare Quality and Access

Contact MHRA

General enquiries

MHRA
10 South Colonnade
London
E14 4PU
United Kingdom

Email

info@mhra.gov.uk

Telephone

020 3080 6000

Fax

020 3118 9803

Office hours are Monday to Friday, 9am to 5pm.

Media enquiries

News centre
MHRA10 South Colonnade
London
E14 4PU
United Kingdom

Email

newscentre@mhra.gov.uk

Telephone (including out of hours):

020 3080 7651

Make an FOI request

  1. Read about the Freedom of Information (FOI) Act and how to make a request.
  2. Check our previous releases to see if we’ve already answered your question.
  3. Make a new request by contacting us using the details below.

Freedom of Information

MHRA Freedom of Information Team
10 South Colonnade
London
E14 4PU
United Kingdom

Email

foi.request@mhra.gov.uk

FOI contact form

Corporate information

Jobs and contracts

Read our policy on Social media use.